Fresh analysis suggests that patients who discontinue new GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt conventional lifestyle programs.
Published data in a prominent health publication shows that while overweight people can lose about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications need to be cognizant of the potential of rapid weight regain when the treatment concludes," stated expert Dr. Susan Jebb.
This pace of regain suggests a reversion to pre-treatment mass in about one and a half years.
Weighing Approaches
The analysis, which reviewed 37 of studies involving thousands of patients, compared the results of these new drugs with older methods.
Scientists point out that people who shed pounds through lifestyle changes alone typically experience a less rapid weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Quick Regain
Nutrition scientists suggest the way of the drugs explains the accelerated rebound.
The injections imitate a natural hormone called GLP-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines advise the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals say that, considering the high risk of weight regain, the treatment should be considered ongoing.
This view is supported by drug manufacturers, who note that the findings "underscore the persistent character of obesity," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have stopped the jabs report a powerful return of cravings.
"I experienced something that goes on and you're instantly ravenous," said a patient.
This challenge is exacerbated if users have not developed sustainable lifestyle or habit changes during treatment.
Significant Use
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Use is greater among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while these medications are potent agents for weight loss, they are not a magic cure and long-term success hinges on ongoing lifestyle support.